iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

Lesley Seymour(Queen's University), Jan Bogaerts(European Organisation for Research and Treatment of Cancer), Andrea Perrone(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert Ford(Clinical Research Consulting), Lawrence H. Schwartz(Columbia University Irving Medical Center), Sumithra J. Mandrekar(Mayo Clinic), Nancy U. Lin(Dana-Farber Cancer Institute), Saskia Litière(European Organisation for Research and Treatment of Cancer), Janet Dancey(Queen's University), Alice Chen(National Cancer Institute), F. Stephen Hodi(Dana-Farber Cancer Institute), Patrick Therasse(Servier (France)), Otto S. Hoekstra(Amsterdam UMC Location VUmc), Lalitha Shankar(National Cancer Institute), Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center), Marcus Ballinger(Ludwig Cancer Research), Caroline Caramella(Institut Gustave Roussy), Elisabeth G.E. de Vries(University Medical Center Groningen)
The Lancet Oncology
March 1, 2017
Cited by 2,378Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis